Optimal preloading in radioimmunotherapy with anti-CD45 antibody

Medical Physics

Volumn 38, Issue 5, 2011, Pages 2572-2578

  Kletting, Peter ^a   Kull, Thomas ^a   Bunjes, Donald ^a   Luster, M ^a   Reske, Sven N ^a   Glatting, Gerhard ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

anti CD45 antibody; PBPK model; preloading; radioimmunotherapy

Indexed keywords

ANTIBODIES; DISEASES; MEDICAL COMPUTING; PHARMACOKINETICS; PHYSIOLOGY; RADIOTHERAPY;

CORRECTED AKAIKE INFORMATION CRITERIONS; ESTIMATED PARAMETER; PHARMACOKINETIC MODEL; PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS; PRELOADING; RADIOIMMUNOTHERAPY; RELATIVE DEVIATIONS; SATURATION CONDITIONS;

PHYSIOLOGICAL MODELS;

EID: 79959565374     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3581059     Document Type: Article

References (28)

1. J. L. Dearling and R. B. Pedley, Technological advances in radioimmunotherapy., Clin. Oncol. (R Coll. Radiol.) 19, 457-469 (2007). (Pubitemid 46995619)
2. R. M. Sharkey and D. M. Goldenberg, Perspectives on cancer therapy with radiolabeled monoclonal antibodies., J. Nucl. Med. 46, 115S-127S (2005). (Pubitemid 47619027)
3. S. Knox, Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma., Clin. Cancer Res. 2, 457-470 (1996). (Pubitemid 26100047)
4. G. Glatting., Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia., J. Nucl. Med 47, 1335-1341 (2006). (Pubitemid 47544889)
5. P. Kletting, D. Bunjes, S. N. Reske, and G. Glatting, Improving anti-CD45 antibody radioimmunotherapy using a physiologically based pharmacokinetic model., J. Nucl. Med. 50, 296-302 (2009). 10.2967/jnumed.108.054189
6. F. J. Kirly, P. Kletting, S. N. Reske, and G. Glatting, Modelling radioimmunotherapy with anti-CD45 antibody to obtain a more favourable biodistribution., Nuklearmedizin 48, 113-119 (2009).
7. P. Kletting, Radioimmunotherapy with anti-CD66 antibody: Improving the biodistribution using a physiologically based pharmacokinetic model., J. Nucl. Med. 51, 484-491 (2010). 10.2967/jnumed.109.067546
8. P. Kletting, C. Meyer, S. N. Reske, and G. Glatting, Potential of optimal preloading in anti-CD20 antibody radioimmunotherapy: An investigation based on pharmacokinetic modeling., Cancer Biother. Radiopharm. 25, 279-287 (2010). 10.1089/cbr.2009.0746
9. I. Nestorov, Whole-body physiologically based pharmacokinetic models., Expert Opin. Drug. Metab. Toxicol. 3, 235-249 (2007). 10.1517/17425255.3.2.235 (Pubitemid 47321518)
10. K. P. Burnham and D. R. Anderson, Model Selection and Multimodel Interference-A Practical Information-Theoretic Approach, 2nd ed. (Springer, New York, 2002).
11. P. Kletting, T. Kull, S. N. Reske, and G. Glatting, Comparing time activity curves using the Akaike information criterion., Phys. Med. Biol. 54, N501-N507 (2009). 10.1088/0031-9155/54/21/N01
12. P. Kletting and G. Glatting, Model selection and inference in pharmacokinetics: The corrected Akaike information criterion and the F-test., Z Med. Phys. 19, 200-206 (2009).
13. G. Glatting, Internal radionuclide therapy: The UlmDos software for treatment planning., Med. Phys. 32, 2399-2405 (2005). 10.1118/1.1945348 (Pubitemid 41023200)
14. J. J. Grudzinski, W. Tome, J. P. Weichert, and R. Jeraj, The biological effectiveness of targeted radionuclide therapy based on a whole-body pharmacokinetic model., Phys. Med. Biol. 55, 5723-5734 (2010). 10.1088/0031-9155/55/19/007
15. P. H. Barrett, SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studies., Metabolism 47, 484-492 (1998). 10.1016/S0026-0495(98)90064-6 (Pubitemid 28180958)
16. 111In-labeled monoclonal antibody in humans., Cancer Res. 47, 3328-3336 (1987). (Pubitemid 17082669)
17. A. Bikoue, F. George, P. Poncelet, M. Mutin, G. Janossy, and J. Sampol, Quantitative analysis of leukocyte membrane antigen expression: normal adult values., Cytometry 26, 137-147 (1996). 10.1002/(SICI)1097-0320(19960615)26:21.0. CO;2-Y (Pubitemid 26238187)
18. J. Westermann and R. Pabst, Distribution of lymphocyte subsets and natural killer cells in the human body., Clin. Investig. 70, 539-544 (1992). 10.1007/BF00184787
19. D. C. Matthews, Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque., Blood 78, 1864-1874 (1991).
20. 90Y-antibody therapy., J. Nucl. Med. 43, 1245-1253 (2002). (Pubitemid 34988774)
21. 99mTc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy., Eur. J. Nucl. Med. Mol. Imaging 30, 667-673 (2003). 10.1007/s00259-002-1106-9 (Pubitemid 36612948)
22. R. F. Meredith, S. Shen, A. Forero, and A. Lobuglio, A method to correct for radioactivity in large vessels that overlap the spine in imaging-based marrow dosimetry of lumbar vertebrae., J. Nucl. Med. 49, 279-284 (2008). 10.2967/jnumed.107.045021 (Pubitemid 351225667)
23. G. L. Ong and M. J. Mattes, Re-evaluation of the concept of functional affinity as applied to bivalent antibody binding to cell surface antigens., Mol. Immunol. 30, 1455-1462 (1993). 10.1016/0161-5890(93)90107-M
24. G. E. Cartwright, J. W. Athens, and M. M. Wintrobe, Analytical review: The kinetics of granulopoiesis in normal man., Blood 24, 780-803 (1964).
25. B. M. Sandmaier, Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts., Blood 100, 318-326 (2002). 10.1182/blood-2001-12-0322 (Pubitemid 35177463)
26. P. Carthew, R. R. Maronpot, J. F. Foley, R. E. Edwards, and B. M. Nolan, Method for determining whether the number of hepatocytes in rat liver is increased after treatment with the peroxisome proliferator gemfibrozil., J. Appl. Toxicol 17, 47-51 (1997). 10.1002/(SICI)1099-1263(199701)17:11.0.CO;2-5 (Pubitemid 27091397)
27. G. Glatting, P. Kletting, S. N. Reske, K. Hohl, and C. Ring, Choosing the optimal fit function: Comparison of the Akaike information criterion and the F-test., Med. Phys. 34, 4285-4292 (2007). 10.1118/1.2794176 (Pubitemid 350029650)
28. R. W. Leggett and L. R. Williams, A proposed blood circulation model for reference man., Health Phys. 69, 187-201 (1995). 10.1097/00004032-199508000- 00003